Apply a thin layer to affected skin twice daily and rub in gently and completely
Limit treatment to 2 consecutive weeks; do not exceed 50 g per week (super-high potency)
Do not use with occlusive dressings
Discontinue when control is achieved; reassess diagnosis if no improvement within 2 weeks
Cautions
HPA-axis suppression / Cushing's syndrome with prolonged use (reported in infants and adults)
Local reactions: skin atrophy, striae, telangiectasia, folliculitis
Allergic contact dermatitis
Secondary skin infection
Adverse reactions
Burning sensation
Irritation
Itching
Stinging
Cracking
Erythema
Skin atrophy
Telangiectasia
Pregnancy Teratogenic in animals when given subcutaneously (cleft palate, skeletal defects); use during pregnancy only if potential benefit justifies risk.
Lactation Undefined
NO BOXED WARNINGS
Principal riskSkin atrophy and striae; axis suppression over large areas